PADI2
Basic information
Region (hg38): 1:17066761-17119451
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (86 variants)
- not_provided (7 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PADI2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000007365.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | |||||
| missense | 84 | 87 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 84 | 4 | 5 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PADI2 | protein_coding | protein_coding | ENST00000375486 | 16 | 52693 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.95e-11 | 0.944 | 125211 | 0 | 536 | 125747 | 0.00213 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.490 | 385 | 413 | 0.932 | 0.0000256 | 4346 |
| Missense in Polyphen | 144 | 167.25 | 0.86101 | 1792 | ||
| Synonymous | 0.167 | 172 | 175 | 0.984 | 0.0000119 | 1295 |
| Loss of Function | 2.07 | 22 | 35.3 | 0.624 | 0.00000193 | 386 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00267 | 0.00265 |
| Ashkenazi Jewish | 0.00112 | 0.00109 |
| East Asian | 0.000272 | 0.000272 |
| Finnish | 0.00134 | 0.00134 |
| European (Non-Finnish) | 0.00313 | 0.00313 |
| Middle Eastern | 0.000272 | 0.000272 |
| South Asian | 0.00219 | 0.00219 |
| Other | 0.000979 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the deimination of arginine residues of proteins. {ECO:0000269|PubMed:12392711, ECO:0000269|PubMed:25621824}.;
- Pathway
- Neutrophil degranulation;Chromatin modifying enzymes;Innate Immune System;Immune System;Chromatin organization;protein citrullination
(Consensus)
Recessive Scores
- pRec
- 0.140
Intolerance Scores
- loftool
- 0.800
- rvis_EVS
- -0.5
- rvis_percentile_EVS
- 21.81
Haploinsufficiency Scores
- pHI
- 0.124
- hipred
- N
- hipred_score
- 0.431
- ghis
- 0.449
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.260
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Padi2
- Phenotype
- immune system phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Zebrafish Information Network
- Gene name
- padi2
- Affected structure
- ocular blood vessel
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- regulation of chromatin disassembly;protein citrullination;substantia nigra development;intracellular estrogen receptor signaling pathway;histone H3-R26 citrullination;histone citrullination;neutrophil degranulation;chromatin-mediated maintenance of transcription;negative regulation of chemokine-mediated signaling pathway;negative regulation of lymphocyte chemotaxis;cellular response to leukemia inhibitory factor
- Cellular component
- extracellular region;nucleus;cytoplasm;cytosol;transcriptionally active chromatin;azurophil granule lumen;extracellular exosome
- Molecular function
- protein-arginine deiminase activity;calcium ion binding;estrogen receptor binding;protein homodimerization activity